Unfolded protein response in endothelial injury

References

• Huppert LA, Matthay MA, Ware LB. Pathogenesis of acute respiratory distress syndrome. Semin Respir Crit Care Med. 2019;40(1):31–39.
   PubMed Web of Science ®Google Scholar
• Bos LDJ, Laffey JG, Ware LB, et al. Towards a biological definition of ARDS: are treatable traits the solution? Intensive Care Med Exp. 2022;10(1):8.
   PubMedGoogle Scholar
• Landolf KM, Lemieux SM, Rose C, et al. Corticosteroid use in ARDS and its application to evolving therapeutics for coronavirus disease 2019 (COVID-19): a systematic review. Pharmacother. 2022;42(1):71–90.
   PubMedGoogle Scholar
• Uddin MA, Barabutis N. P53 in the impaired lungs. DNA Repair (Amst). 2020;95:102952.
   PubMedGoogle Scholar
• Kubra KT, Akhter MS, Uddin MA, et al. P53 versus inflammation: an update. Cell Cycle. 2020;19(2):160–162.
   PubMed Web of Science ®Google Scholar
• Barabutis N, Dimitropoulou C, Birmpas C, et al. p53 protects against LPS-induced lung endothelial barrier dysfunction. Am J Physiol Lung Cell Mol Physiol. 2015;308(8):L776–787.
   PubMed Web of Science ®Google Scholar
• Barabutis N, Dimitropoulou C, Gregory B, et al. Wild-type p53 enhances endothelial barrier function by mediating RAC1 signalling and RhoA inhibition. J Cell Mol Med. 2018;22(3):1792–1804.
   PubMed Web of Science ®Google Scholar
• Uddin MA, Akhter MS, Kubra KT, et al., P53 deficiency potentiates LPS-Induced acute lung injury in vivo.Curr Res Physiol. 2020;3;30–33.
   PubMedGoogle Scholar
• Akhter MS, Uddin MA, Barabutis N. P53 regulates the redox status of lung endothelial cells. Inflammation. 2020;43(2):686–691.
   PubMedGoogle Scholar
• Uddin MA, Akhter MS, Siejka A, et al. P53 supports endothelial barrier function via APE1/Ref1 suppression. Immunobiology. 2019;224(4):532–538.
   PubMed Web of Science ®Google Scholar
• Uddin MA, Barabutis N. P53: the endothelium defender. J Cell Biochem. 2019;120(7):10952–10955.
   Web of Science ®Google Scholar
• Kubra KT, Uddin MA, Akhter MS, et al. Hsp90 inhibitors induce the unfolded protein response in bovine and mice lung cells. Cell Signal. 2020;67:109500.
   PubMedGoogle Scholar
• Akhter MS, Uddin MA, Schally AV, et al. Involvement of the unfolded protein response in the protective effects of growth hormone releasing hormone antagonists in the lungs. J Cell Commun Signal. 2021;15(1):125–129.
   PubMedGoogle Scholar
• Uddin MA, Kubra KT, Sonju JJ, et al. Effects of heat shock protein 90 inhibition in the lungs. Med Drug Discov. 2020;6. doi:10.1016/j.medidd.2020.100046.
   Google Scholar
• Kubra KT, Uddin MA, Akhter MS, et al. P53 mediates the protective effects of metformin in inflamed lung endothelial cells. Int Immunopharmacol. 2021;101(Pt B):108367.
   PubMedGoogle Scholar
• Uddin MA, Akhter MS, Kubra KT, et al. Metformin in acute respiratory distress syndrome: an opinion. Exp Gerontol. 2021;145:111197.
   PubMedGoogle Scholar
• Clerico EM, Gierasch LM. There are more Hsp90 chaperone mechanisms in heaven and earth, dear reader, than are dreamt of in your philosophy. Mol Cell. 2022;82(8):1403–1404.
   PubMedGoogle Scholar
• Chatterjee A, Dimitropoulou C, Drakopanayiotakis F, et al. Heat shock protein 90 inhibitors prolong survival, attenuate inflammation, and reduce lung injury in murine sepsis. Am J Respir Crit Care Med. 2007;176(7):667–675.
   PubMedGoogle Scholar
• Barabutis N. P53 in acute respiratory distress syndrome. Cell Mol Life Sci. 2020;77(22):4725–4727.
   PubMedGoogle Scholar
• Cai R, Zhang X, Wang H, et al. Synthesis of potent antagonists of receptors for growth hormone-releasing hormone with antitumor and anti-inflammatory activity. Peptides. 2022;150:170716.
   PubMedGoogle Scholar
• Schally AV, Zhang X, Cai R, et al. Actions and potential therapeutic applications of growth hormone-releasing hormone agonists. Endocrinology. 2019;160(7):1600–1612.
   PubMedGoogle Scholar
• Barabutis N. Growth hormone releasing hormone in endothelial barrier function. Trends Endocrinol Metab. 2021;32(6):338–340.
   PubMed Web of Science ®Google Scholar
• Barabutis N, Schally AV. Growth hormone-releasing hormone: extrapituitary effects in physiology and pathology. Cell Cycle. 2010;9(20):4110–4116.
   PubMed Web of Science ®Google Scholar
• Havt A, Schally AV, Halmos G, et al. The expression of the pituitary growth hormone-releasing hormone receptor and its splice variants in normal and neoplastic human tissues. Proc Natl Acad Sci USA. 2005;102(48):17424–17429.
   PubMed Web of Science ®Google Scholar
• Barabutis N, Schally AV, Siejka A. P53, GHRH, inflammation and cancer. EBioMedicine. 2018;37:557–562.
   PubMed Web of Science ®Google Scholar
• Zarandi M, Horvath JE, Halmos G, et al. Synthesis and biological activities of highly potent antagonists of growth hormone-releasing hormone. Proc Natl Acad Sci USA. 1994;91(25):12298–12302.
   PubMedGoogle Scholar
• Barabutis N. A glimpse at growth hormone-releasing hormone cosmos. Clin Exp Pharmacol Physiol. 2020;47(9):1632–1634.
   PubMedGoogle Scholar
• Akhter MS, Kubra KT, Uddin MA, et al. An antagonist of growth hormone-releasing hormone protects against LPS-induced increase of bronchoalveolar lavage fluid protein concentration. Inflamm Res. 2022;71(2):183–185.
   PubMedGoogle Scholar
• Antonov A, Snead C, Gorshkov B, et al. Heat shock protein 90 inhibitors protect and restore pulmonary endothelial barrier function. Am J Respir Cell Mol Biol. 2008;39(5):551–559.
   PubMed Web of Science ®Google Scholar
• Chatterjee A, Snead C, Yetik-Anacak G, et al. Heat shock protein 90 inhibitors attenuate LPS-induced endothelial hyperpermeability. Am J Physiol Lung Cell Mol Physiol. 2008;294(4):L755–763.
   PubMedGoogle Scholar
• Akhter MS, Uddin MA, Kubra KT, et al. Elucidation of the molecular pathways involved in the protective effects of AUY-922 in LPS-induced inflammation in mouse lungs. Pharmaceuticals (Basel). 2021;14(6):522.
   PubMedGoogle Scholar
• Hetz C, Zhang K, Kaufman RJ. Mechanisms, regulation and functions of the unfolded protein response. Nat Rev Mol Cell Biol. 2020;21(8):421–438.
   PubMed Web of Science ®Google Scholar
• Ren J, Bi Y, Sowers JR, et al. Endoplasmic reticulum stress and unfolded protein response in cardiovascular diseases. Nat Rev Cardiol. 2021;18(7):499–521.
   PubMed Web of Science ®Google Scholar
• Diaz-Hung ML, Martinez G, Hetz C. Emerging roles of the unfolded protein response (UPR) in the nervous system: a link with adaptive behavior to environmental stress? Int Rev Cell Mol Biol. 2020;350:29–61.
   PubMedGoogle Scholar
• Barabutis N. Unfolded protein response in lung health and disease. Front Med (Lausanne). 2020;7:344.
   PubMedGoogle Scholar
• Bartoszewska S, Collawn JF. Unfolded protein response (UPR) integrated signaling networks determine cell fate during hypoxia. Cell Mol Biol Lett. 2020;25:18.
   PubMedGoogle Scholar
• Barabutis N. unfolded protein response supports endothelial barrier function. Biochimie. 2019;165:206–209.
   PubMed Web of Science ®Google Scholar
• Blackwood EA, Azizi K, Thuerauf DJ, et al. Pharmacologic ATF6 activation confers global protection in widespread disease models by reprograming cellular proteostasis. Nat Commun. 2019;10(1):187.
   PubMedGoogle Scholar
• Zuehlke AD, Moses MA, Neckers L. Heat shock protein 90: its inhibition and function. Philos Trans R Soc Lond B Biol Sci. 2018;373(1738):20160527.
   PubMedGoogle Scholar
• Akhter MS, Kubra KT, Uddin MA, et al. Kifunensine compromises lung endothelial barrier function. Microvasc Res. 2020;132:104051.
   PubMedGoogle Scholar
• Kubra KT, Uddin MA, Akhter MS, et al., Luminespib counteracts the Kifunensine-induced lung endothelial barrier dysfunction.Curr Res Toxicol. 2020;1;111–115.
   PubMedGoogle Scholar
• Barabutis N. Insights on supporting the aging brain microvascular endothelium. Aging Brain. 2021;1. doi:10.1016/j.nbas.2021.100009.
   Google Scholar
• Kubra KT, Barabutis N. Brefeldin A and kifunensine modulate LPS-induced lung endothelial hyperpermeability in human and bovine cells. Am J Physiol Cell Physiol. 2021;321(2):C214–C220.
   PubMedGoogle Scholar
• Kubra KT, Uddin MA, Barabutis N. Tunicamycin protects against LPS-induced lung injury. Pharmaceuticals (Basel). 2022;15(2):134.
   PubMedGoogle Scholar
• Barabutis N, Akhter MS, Uddin MA, et al. GHRH antagonists protect against hydrogen peroxide-induced breakdown of brain microvascular endothelium integrity. Horm Metab Res. 2020;52(5):336–339.
   PubMed Web of Science ®Google Scholar
• Uddin MA, Akhter MS, Kubra KT, et al. Hsp90 inhibition protects brain endothelial cells against LPS-induced injury. Biofactors. 2022. 10.1002/biof.1833
   PubMedGoogle Scholar
• Uddin MA, Akhter MS, Kubra KT, et al. Hsp90 inhibition protects the brain microvascular endothelium against oxidative stress. Brain Disord. 2021;1. doi:10.1016/j.dscb.2020.100001.
   Google Scholar
• Wood H. VEGFA mediates blood-brain barrier disruption in Parkinson disease. Nat Rev Neurol. 2022;18(1):1.
   Google Scholar
• Akhter MS, Uddin MA, Barabutis N. Unfolded protein response regulates P53 expression in the pulmonary endothelium. J Biochem Mol Toxicol. 2019;33(10):e22380.
   PubMed Web of Science ®Google Scholar
• Barabutis N. Regulation of lung endothelial permeability by NEK kinases. IUBMB Life. 2020;72(4):801–804.
   PubMed Web of Science ®Google Scholar
• Fry AM, O’Regan L, Sabir SR, et al. Cell cycle regulation by the NEK family of protein kinases. J Cell Sci. 2012;125(Pt 19):4423–4433.
   PubMed Web of Science ®Google Scholar
• Moniz L, Dutt P, Haider N, et al. Nek family of kinases in cell cycle, checkpoint control and cancer. Cell Div. 2011;6(1):18.
   PubMedGoogle Scholar
• Uddin MA, Akhter MS, Kubra KT, et al. Induction of the NEK family of kinases in the lungs of mice subjected to cecal ligation and puncture model of sepsis. Tissue Barriers. 2021;9(4):1929787.
   PubMedGoogle Scholar